Cronos Group Inc (NASDAQ:CRON) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting worse-than-expected third-quarter results.
Tilray Brands Inc reported a 16.8% increase in net revenue for the third quarter ended Feb. 29, 2024, with $188.3 million in total revenue, marking a 30% year-over-year rise. The company saw significant growth in beverage-alcohol net revenue, up 165% to $54.7 million, and global cannabis net revenue increased by 33% to $63.4 million, with international cannabis growing by 44% compared to the previous year quarter.
Chairman and CEO Irwin D. Simon highlighted various accomplishments during the quarter…Read More
Is CRON A Good Stock To Buy?
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action ...